193201-63-7 Usage
Chemical class
Spiro compounds
Explanation
1,4-Dioxa-8-azaspiro[4.5]decane, 7-(phenylmethyl)- belongs to a class of organic compounds that have two rings connected by a single atom.
Explanation
Due to its spirocyclic structure, 1,4-Dioxa-8-azaspiro[4.5]decane, 7-(phenylmethyl)- may have unique properties and potential biological activities that could be useful in the development of drugs or agrochemical agents.
Explanation
Further studies are needed to understand the compound's properties, such as its chemical reactivity, stability, and potential interactions with biological systems. This research could reveal its suitability as a drug candidate or an agrochemical agent.
Explanation
The specific biological activities of 1,4-Dioxa-8-azaspiro[4.5]decane, 7-(phenylmethyl)- are not yet known, and further research is required to determine its potential as a drug candidate or an agrochemical agent.
Explanation
The chemical formula represents the composition of the compound, indicating the number of carbon (C), hydrogen (H), nitrogen (N), and oxygen (O) atoms present in the molecule.
Explanation
The molecular weight is the sum of the atomic weights of all the atoms in the molecule, which can be used to calculate the mass of a specific quantity of the compound.
Explanation
The solubility of the compound in various solvents is not yet known and would need to be determined through experimental studies.
Explanation
The stability of the compound under different conditions, such as temperature, pressure, and exposure to light or moisture, is not yet known and would need to be investigated.
Explanation
The reactivity of the compound with other chemicals or under different conditions is not yet known and would need to be studied to understand its potential applications and limitations.
Unique structure
Spiro ring with a phenylmethyl group at the 7th position
Potential applications
Pharmaceutical and agricultural industries
Research focus
Exploration of properties and potential applications
Biological activities
Unknown at this stage
Molecular weight
Approximately 221.28 g/mol
Solubility
Unknown at this stage
Stability
Unknown at this stage
Reactivity
Unknown at this stage
Check Digit Verification of cas no
The CAS Registry Mumber 193201-63-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,3,2,0 and 1 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 193201-63:
(8*1)+(7*9)+(6*3)+(5*2)+(4*0)+(3*1)+(2*6)+(1*3)=117
117 % 10 = 7
So 193201-63-7 is a valid CAS Registry Number.
193201-63-7Relevant academic research and scientific papers
A Robust, Recyclable Resin for Decagram Scale Resolution of (±)-Mefloquine and Other Chiral N-Heterocycles
Kreituss, Imants,Chen, Kuang-Yen,Eitel, Simon H.,Adam, Jean-Michel,Wuitschik, Georg,Fettes, Alec,Bode, Jeffrey W.
supporting information, p. 1553 - 1556 (2016/02/12)
Decagram quantities of enantiopure (+)-mefloquine have been produced via kinetic resolution of racemic mefloquine using a ROMP-gel supported chiral acyl hydroxamic acid resolving agent. The requisite monomer was prepared in a few synthetic steps without chromatography and polymerization was safely performed on a >30 gram scale under ambient conditions. The reagent was readily regenerated and reused multiple times for the resolution of 150 grams of (±)-mefloquine and other chiral N-heterocylces.
Process development of the synthetic route to R116301
Guillaume, Michel,Cuypers, Jef,Dingenen, Jul
, p. 1079 - 1086 (2012/12/30)
We describe in this paper the synthesis of compound 1 (R116301), which was developed to prepare pilot scale quantities (20-50 kg) of drug substance. The synthesis involves the sBuLi deprotonation of Boc-protected piperidone acetal 2, followed b
SUBSTITUTED 1,4-DI-PIPERIDIN-4-YL-PIPERAZINE DERIVATIVES AND THEIR USE AS NEUROKININ ANTAGONISTS
-
Page 32, (2008/06/13)
The invention concerns substituted 1,4-di-piperidin-4-yl-piperazine derivatives having neurokinin antagonistic activity, in particular NK1 antagonistic activity, their preparation, compositions comprising them and their use as a medicine, in particular fo
(Benzimidazolyl- and imidazopyridinyl) containing 1-(1,2-disubstituted piperidinyl) derivatives
-
, (2008/06/13)
This invention concerns the compounds of formula the N-oxide forms, the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein n is 0, 1 or 2; m is 1 or 2, provided that if m is 2, then n is 1; X is a covalent
